Ventura Forecasts 39% Upside for Small-Cap Health Care Stock, Issues "Buy" Recommendation
Park Medi World Initiates Coverage with 'Buy' Rating by Ventura Securities
Company Overview Park Medi World (PMWL), a relatively new listed entity, has been initiated coverage by Ventura Securities with a 'Buy' rating. The brokerage firm has assigned a target price of Rs 284, indicating an upside potential of 38.4% over the next 24 months.
Key Drivers The hospital chain is expected to benefit from structural tailwinds, capacity expansion, and a capital-efficient operating model. PMWL's operating model positions it well among peers, particularly in the affordable healthcare segment, where scale, cost efficiency, and execution are key.
Valuation Ventura has assigned a discounted cash flow-based target price of Rs 284, implying a valuation of 28.2 times FY28 price-to-earnings ratio, compared to the current market price of Rs 205.
Risks The brokerage has flagged risks, including slower-than-expected occupancy ramp-up in newly commissioned hospitals.
Trading Details Shares of PMWL were trading lower at Rs 200.09 per share on the NSE, down 2.57%. The company listed in December 2025 and is trading about 29% above the issue price of Rs 162.
Investor Takeaway
Investors should consider Park Medi World for its high-growth opportunity in the affordable healthcare segment.
More in IPO
SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire
SMR Jewels IPO Successfully Lists with Institutional Support
Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO
